Speaking pretty good English, Dr Tayeb came straight to the point. Was I eligible for the ground breaking new cancer treatment? He was afraid not. The radioactive test scan had illuminated the bone tumours very nicely, but the more dangerous one in the liver had remained occluded. So in my case the new treatment – a series of targeted infusions – could have only a ‘suboptimal outcome’.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in